{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-25-007625","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.275891+00:00","generated_at":"2026-05-19T12:53:22.644510+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tonix enters $150M ATM equity facility and $75M Lincoln Park purchase agreement","bullets":["ATM facility with A.G.P. allows sale of up to $150M in common stock at 3% commission.","Lincoln Park Purchase Agreement enables up to $75M in stock sales with 97% of VWAP pricing.","Issued 48,708 commitment shares to Lincoln Park as fee; no upper price limit for purchases.","Lincoln Park purchases capped at 1,470,703 shares (19.99% of outstanding) unless stockholder approval or price ≥$37.74.","Proceeds expected for working capital and general corporate purposes; existing shelf registration utilized."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-25-007625","json":"https://secwatch.observer/filing/0001999371-25-007625.json","markdown":"https://secwatch.observer/filing/0001999371-25-007625.md","text":"https://secwatch.observer/filing/0001999371-25-007625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/0001999371-25-007625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/tnxp-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T12:53:22.644510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}